Cargando…
An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552729/ https://www.ncbi.nlm.nih.gov/pubmed/36220820 http://dx.doi.org/10.1038/s41392-022-01207-4 |
| _version_ | 1784806310914555904 |
|---|---|
| author | Sang, Ye Zhang, Zhen Li, Entao Lu, Haitao Long, Jinrong Cao, Yiming Yu, Changxiao Wang, Tiecheng Yang, Jing Wang, Shengqi |
| author_facet | Sang, Ye Zhang, Zhen Li, Entao Lu, Haitao Long, Jinrong Cao, Yiming Yu, Changxiao Wang, Tiecheng Yang, Jing Wang, Shengqi |
| author_sort | Sang, Ye |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9552729 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95527292022-10-11 An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 Sang, Ye Zhang, Zhen Li, Entao Lu, Haitao Long, Jinrong Cao, Yiming Yu, Changxiao Wang, Tiecheng Yang, Jing Wang, Shengqi Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-10-11 /pmc/articles/PMC9552729/ /pubmed/36220820 http://dx.doi.org/10.1038/s41392-022-01207-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Sang, Ye Zhang, Zhen Li, Entao Lu, Haitao Long, Jinrong Cao, Yiming Yu, Changxiao Wang, Tiecheng Yang, Jing Wang, Shengqi An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title | An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title_full | An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title_fullStr | An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title_full_unstemmed | An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title_short | An mRNA vaccine with broad-spectrum neutralizing protection against Omicron variant sublineages BA.4/5 -included SARS-CoV-2 |
| title_sort | mrna vaccine with broad-spectrum neutralizing protection against omicron variant sublineages ba.4/5 -included sars-cov-2 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552729/ https://www.ncbi.nlm.nih.gov/pubmed/36220820 http://dx.doi.org/10.1038/s41392-022-01207-4 |
| work_keys_str_mv | AT sangye anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT zhangzhen anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT lientao anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT luhaitao anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT longjinrong anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT caoyiming anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT yuchangxiao anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT wangtiecheng anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT yangjing anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT wangshengqi anmrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT sangye mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT zhangzhen mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT lientao mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT luhaitao mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT longjinrong mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT caoyiming mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT yuchangxiao mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT wangtiecheng mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT yangjing mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 AT wangshengqi mrnavaccinewithbroadspectrumneutralizingprotectionagainstomicronvariantsublineagesba45includedsarscov2 |